1.
J Ark Med Soc
; 101(3): 86-90, 2004 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15384500
RESUMO
Atopic Dermatitis (AD) is a common cutaneous inflammatory disease. Recent estimates of prevalence in United States school children range from 10-20%. Topical treatment of AD is unsatisfactory. Now two new topical agents, tacrolimus and pimecrolimus, are revolutionizing the treatment of AD. Here we review AD as well as these breakthrough therapies.